ChristopherLindMD

Biliary Tract Disease, Esophagus Disease, Gastrointestinal Functional & Motility Disorders

Professor, Medicine, Vanderbilt University School of Medicine

Dr. Lind is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

America's Top Doctors Castle Connolly, 2004-2014
Nashville Lifestyles Magazine Castle Connolly, 2006, 2013-2014
Fellow (AGAF) American Gastroenterological Association, 2012
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACP) American College of Physicians, 2006
Top MD Consumers Checkbook
Join now to see all

PubMed

158 citations
Possible role of transforming growth factor α in the pathogenesis of Ménétrier's disease: Supportive evidence from humans and transgenic mice
Peter J. Dempsey, James R. Goldenring, Carol J. Soroka, Irvin M. Modlin, Robert W. McClure
Gastroenterology. 1992-12-01
57 citations
Distinguishing Ménétrier’s Disease from its Mimics
Amy Rich, Tania Zuluaga Toro, Jarred P. Tanksley, William H. Fiske, Christopher D. Lind
Gut. 2010-12-01
45 citations
Efficacy of Cetuximab in the Treatment of Ménétrier’s Disease
William H. Fiske, Jarred P. Tanksley, Ki Taek Nam, James R. Goldenring, Robbert J.C. Slebos
Science Translational Medicine. 2009-11-25